Fig 1: The Correlation of LAMB1 with SCH and Analysis of Its Clinical Predictive Value. Note: A Comparison of general data between normal patients and SCH patients (Normal, n = 10; SCH, n = 10); B Comparison of routine blood test indicators between normal patients and SCH patients, with WBC as white blood cell count, Hb as hemoglobin, PLT as platelet count, and HCT as hematocrit; C Comparison of coagulation function indicators between normal patients and SCH patients, including PT as prothrombin time, APTT as activated partial thromboplastin time, TT as thrombin time, Fib as fibrinogen, DD as a marker of thrombus formation and dissolution, FDP as fibrinogen degradation products, and ATIII as antithrombin III; D ELISA detection of LAMB1 concentration in the serum of normal patients and SCH patients; E IHC and H&E staining analysis of TNF-α, IL-10, TSP-1, and CD34 expression in chorionic villi and decidual tissues of normal patients and SCH patients, with a scale of 50 μm, where positive expression is observed as yellow or brownish-yellow granules in the cytoplasm under the microscope, with < 10% positive cell count considered negative expression and ≥ 10% as positive expression; F-G Comparison of the positive rates of TNF-α, IL-10, TSP-1, and CD34 in chorionic villi and decidual tissues of normal patients and SCH patients; H ELISA detection of TNF-α, IL-10, TSP-1, and CD34 concentrations in the serum of normal patients and SCH patients; I-J Spearman correlation analysis of LAMB1 with TNF-α, IL-10, TSP-1, and CD34 expression. Normal, n = 10; SCH, n = 10, quantitative data presented as mean ± standard deviation, with unpaired t-test used for intergroup comparison. * indicates p < 0.05 in the comparison between the two groups, and ns indicates no statistically significant difference between the two groups, with * representing the significance level